Impact of Prior Virological Failure and Nucleos(t)ide Genotypic Resistance Mutations on the Efficacy of Switching from Ritonavir-Boosted Protease Inhibitors to Raltegravir
暂无分享,去创建一个
D. Podzamczer | J. Mallolas | E. Martinez | J. Blanco | M. Laguno | M. Loncá | J. Murillas | F. Gutiérrez | J. Llibre | J. Gatell | A. González-Cordón | E. Fumero | I. Pérez | M. Calvo | M. Martínez-Rebollar | M. Martinez-Rebollar